Search

CyberKnife is a brand name for one of several available stereotactic radiosurgery devices that deliver radiation with linear accelerators. MSK uses a similar device, made by a company called Varian, that destroys tumors with extremely precise, very intense doses of radiation.

… Monday, February 24, 2014 Summary CyberKnife is a brand name. It refers to a stereotactic body radiation therapy device that delivers radiation using advanced imaging technology. MSK uses similar technology as part of an approach called MSK Precise TM . This method destroys tumors with very intense doses

Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.

… Monday, November 23, 2020 Summary Genetic mutations that give cancers a metabolic boost may also leave them vulnerable to drugs that promote a particular form of cell death, Sloan Kettering Institute researchers have found. If there is a silver lining in cancer’s chaotic biology, it’s that the same traits

Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology.

… Wednesday, October 1, 2025 Memorial Sloan Kettering Cancer Center (MSK) presented new research on a range of important topics at the 2025 Annual Meeting of the American Society for Radiation Oncology (ASTRO), held September 27 to October 1 in San Francisco. The presentations included two clinical trials

Get an inside look into the life of a student from the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences.

… Tuesday, November 23, 2021 As a student at the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences, you will join the laboratory of one of more than 130 scientists from Memorial Sloan Kettering Cancer Center with expertise in cancer biology, genomics, immunology, structural biology,

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.

… Wednesday, August 19, 2015 Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer

Learn why MSK researchers developed MACHETE, a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models.

… Monday, November 7, 2022 Highlights MACHETE is a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models. Using MACHETE, researchers found that a prominent deletion often eliminates a cluster of interferon genes — leading to poorer outcomes in mouse models of

In recognition of his contributions in basic science related to cancer research, Sloan Kettering Institute Director Thomas J. Kelly has been awarded the 2004 Alfred P. Sloan, Jr. Prize by the General Motors Cancer Research Foundation.

… Wednesday, June 9, 2004 Summary In recognition of his contributions in basic science related to cancer research, Sloan Kettering Institute Director Thomas J. Kelly has been awarded the 2004 Alfred P. Sloan, Jr. Prize by the General Motors Cancer Research Foundation. In recognition of his contributions

Everyone knows that cigarettes cause cancer. But what do we know about how they do it?

… Friday, December 7, 2018 Summary Scientists are learning how the carcinogens in cigarette smoke interact with DNA to promote cancer. This molecular information complements the well-known epidemiological links between smoking and cancer. That cigarettes cause cancer is no secret. In addition to about

Research fellow Shaniqua Hayes joined the Jason Lewis Lab at the Sloan Kettering Institute (SKI) and Memorial Hospital about a year ago, after attending an online postdoc recruiting event and picking up “good vibes” about SKI.

… Friday, September 30, 2022 Research fellow Shaniqua Hayes Shaniqua Hayes joined the Jason Lewis Lab Jason Lewis Lab at the  Sloan Kettering Institute (SKI) Sloan Kettering Institute (SKI)  and Memorial Hospital about a year ago, after attending an online postdoc recruiting event and picking up “good

In a pivotal move to revolutionize the clinical research landscape, the MSK Clinical Research Innovation Consortium (CRIC) held its inaugural kick-off meeting in November 2025. Spearheaded by founding member MSK, the meeting welcomed new CRIC members Moffitt Cancer Center, Huntsman Cancer Institute, and the Tisch Cancer Center of Mount Sinai Health System.

… Friday, March 6, 2026 In a pivotal move to revolutionize the clinical research landscape, the MSK Clinical Research Innovation Consortium ( CRIC ) held its inaugural kick-off meeting in November 2025. Spearheaded by founding member MSK, the meeting welcomed new CRIC members Moffitt Cancer Center, Huntsman